Background: Interplays between inflammation and mitochondrial biology are reported. Here, we examined the cross-sectional interrelationships of mitochondrial DNA copy number (mtDNA CN ) and inflammation and their interaction with physical functioning. Methods: A total of 1990 community-dwelling adults aged 65 years and older who were participating in the Healthy Aging Longitudinal Study in Taiwan underwent measurements of peripheral-blood leukocytes MtDNA CN , multiple inflammatory markers, grip strength, and gait speed.
With population aging globally, physical functioning impairment is becoming a major health concern (1) (2) (3) (4) . This age-related physical functioning decline is postulated to have a distinct, although still unclear, underlying mechanism that is closely related to aging and age-related diseases (5, 6) .
Low-grade systemic inflammation, which manifests as an agerelated increase in levels of systemic inflammatory markers/mediators, is common in older adults (7) . These high circulating levels of inflammatory markers/mediators were consistently observed to be associated with poor physical functioning, including low grip strength and gait speed (8) (9) (10) (11) . However, the biological basis for these observed relationships between elevated systemic inflammatory markers and impaired physical functioning remains elusive.
Having its own genome encoding key components of the respiratory chain, the mitochondrion acts as the hub of multiple metabolic pathways critical for maintaining homeostasis, which include (but are not limited to) oxidative phosphorylation, macromolecules biosynthesis, ion homeostasis, and redox signaling (12) . To fulfill these physiological roles, adequate mitochondrial biogenesis, particularly mitochondrial DNA (mtDNA) replications, is necessary (12, 13) . Nevertheless, there is a decline in mitochondrial biogenesis during aging, which is increasingly recognized as playing key roles in various biological processes involved in aging (7, 14) . Recent studies have indeed demonstrated associations of mitochondrial biogenesis/function markers with physical functioning in older adults, a phenomenon that remains to be elucidated (14) (15) (16) (17) .
Emerging evidence indicates crosstalk between inflammation and mitochondrial biology. Inflammation has been long known to exert effects on immune cells' mitochondrial biogenesis/function through multiple mechanisms (18) (19) (20) . Recently, mechanistic studies have revealed a more complicated picture and implicates mitochondria in the development of chronic low-grade systemic inflammation (7, 21) . Notably, inflammatory cells with declined mitochondrial biogenesis/function could promote a distinct selfsustaining and pathogenic systemic inflammation (21) (22) (23) . These interplays suggest a possible synergistic effect of inflammation and leukocytes' mitochondrial biogenesis/function on the impairment of physical functioning during aging. A decline in mitochondrial biogenesis/function in leukocytes during aging could elicit a distinct pathogenic systemic inflammation, thereby strengthening the association between elevated systemic inflammatory markers and impaired physical functioning. Low-grade systemic inflammation could promote the expansion of inflammatory cells with declined mitochondrial biogenesis/function, thus strengthening the association of altered mitochondrial biology with impaired physical functioning.
The mtDNA content of a cell, which is determined mostly by the mtDNA replication rate, reflects the activity of mitochondrial biogenesis (12, 13, 24) . As a noninvasive and potentially clinically applicable method, peripheral-blood leukocyte mitochondrial DNA copy number (mtDNA CN ) measurement enables determining the possibility of mitochondrial involvement in various clinical conditions and has been increasingly used as a general indicator of reduced mitochondrial biogenesis and function (25) (26) (27) (28) .
As an initial step towards further clarifying the roles of mitochondrial biology and inflammation in physical functioning impairment during aging, we examined the interrelationship of peripheral-blood leukocytes mtDNA CN with systemic inflammatory markers and their interaction with physical functioning in a sample of community-dwelling disability-free older adults. We hypothesized that the mtDNA CN of peripheral-blood leukocytes would correlate with inflammatory markers and that the mtDNA CN would modify the association between inflammatory markers and physical functioning.
Methods

Participants
The Healthy Aging Longitudinal Study in Taiwan (HALST) is an ongoing population-based longitudinal study (see Supplementary Material) (29) . A total of 2,218 adults aged 65 and older underwent baseline examinations between October 2008 and October 2010. We excluded 228 older adults from the present study for the following reasons: Inadequate amount or lack of DNA for mtDNA CN measurement (n = 167); missing data on inflammatory markers (n = 40) or physical functioning (n = 22 
Mitochondrial DNA Copy Number Measurement
The relative mtDNA CN was measured in accordance with the protocols described by Liu and colleagues, which has been widely used to measure mtDNA CN in a variety of conditions, including those carrying high loads of mutations in mitochondrial DNA (26, 30) . A total of 200 ng of leukocyte total cellular DNA extracted from the buffy coat of centrifuged whole blood was subjected to a fluorescence-based quantitative polymerase chain reaction to amplify a mitochondrial gene (ND1 gene) and a nuclear gene (β-globin gene). The primers of the ND1gene were forward, 5'-AACATACCCATGGCCAACCT-3'; and reverse, 5'-AGCGAAGGGTTGTAGTAGCCC-3'. The primers of the β-globin gene were forward, 5'-GAAGAGCCAAGGACAGGTAC-3'; and reverse, 5'-CAACTTCATCCACGTTCACC-3'. The mtDNA CN was then estimated according to the threshold cycle numbers of these two genes. The intra-assay coefficient of variation was 10.29%. Laboratory personnel who conducted the assays were blinded to all clinical information, including physical functioning, and biomarker measurements.
Inflammatory Marker Measurement
Serum levels of high-sensitivity C-reactive protein (hs-CRP) were measured using a latex-enhanced immunoturbidimetric assay. The tumor necrosis factor receptor 1 (TNFR1), interleukin-6 (IL-6), soluble interleukin-6 receptor (sIL-6r) were measured using enzymelinked immunosorbent assays. A total white blood cell (WBC) count measurement was performed using an automated hematology analyzer (XE-2100, Sysmex, Kobe, Japan). Fibrinogen levels were determined by Clauss method using the Sysmex CA-1500 System (Siemens AG, Munich, Germany). Coagulation is increasingly acknowledged as a key player in inflammation (31) . The levels of D-dimer were measured using an automated latex-enhanced quantitative immunoturbidimetric assay with the Sysmex CA-1500 System. The intra-assay coefficient of variation of each of these measurements was within acceptable ranges. The details could be found in Supplementary Material. Personnel of the laboratory who measured inflammatory markers were blinded to the physical functioning and mtDNA CN status of the participants.
Assessment of Physical Functioning
Muscle strength was assessed by measuring hand grip strength using a North Coast hand dynamometer (North Coast Medical Inc., Gilroy, CA) (29) . While sitting in a chair with the elbow flexed at 90°, the participants were instructed to squeeze the dynamometer with one hand as hard as they could. Three such trials were conducted for each hand in turn. The maximum value for either hand was used for analysis.
In order to measure gait speed, the participants were instructed to take a 4-m walk at their usual pace (4, 29) . Time was measured by a trained examiner with a hand-held stopwatch that measured to the nearest hundredth of a second. Gait speed was calculated as the walking distance (meters) divided by time (second).
We defined "low" grip strength as present if a participant had a maximum hand grip strength at or below the sex-specific median (35 kg in men and 21 kg in women). "Low" gait speed was defined as present if a participant had a gait speed at or below the sex-specific median (0.82 m/s in men and 0.70 m/s in women). The participants were subsequently categorized into one of the following three subclasses based on the degree of multiple impairments in physical functioning: normal grip strength and gait speed (normal physical functioning); low grip strength or low gait speed (moderate physical functioning impairment); and low grip strength and gait speed (severe physical functioning impairment) (6) .
To assess the robustness of our findings, sensitivity analyses, using an alternative definition of impaired physical functioning based on a hand grip strength cut-off point of 30 kg in men and 20 kg in women and a gait speed cut-off point of 0.80 m/s (32), were performed.
Covariates
Covariates included age (years); sex; marital status (unmarried, divorced, widowed, married); education level (< high school, high school, > high school); smoking status (current, previous, never); comorbidities (hypertension, diabetes mellitus, stroke, cardiovascular disease, arthritis, chronic kidney disease, cancer, lung disease); metabolic markers (fasting glucose, insulin resistance, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, albumin, BMI and waist circumference); and endothelial function marker (urinary albumin-to-creatinine ratio) (see Supplementary Material for more detail).
Statistical Analysis
Descriptive statistics were used to characterize the population. Normally distributed continuous variables are presented as mean ± SD, whereas data that were skewed are presented as median and interquartile range. Comparisons among participants with different physical functioning were made using one-way analysis of variance and chi-square tests. Age, mtDNA CN , inflammatory, metabolic, and endothelial function markers were analyzed as continuous variables, whereas other covariates were analyzed as categorical variables. When necessary, data were normalized using natural log-transformation.
To integrate information provided by the multiple inter-correlative inflammatory markers and gain insight into underlying inflammatory processes, principle component analysis (PCA) was applied to extract an underlying low-dimensional representation of the data (inflammatory factors) that explains the variations as much as possible (33) . Each inflammatory factor could be interpreted as representing inflammatory markers with a high absolute value of factor loadings. A participant's score on each factor could then be calculated.
Relationships between the mtDNA CN and inflammatory factors were explored by simple linear correlations. Independent influence of the mtDNA CN on inflammatory factors was then established through multiple stepwise linear regression analysis (stepping method criteria: probability of F to enter ≤ .05 and to remove ≥ .10). Adjustments were made for three models as follows: model 1 (adjustment for age, sex, marital status, education level, and smoking status); model 2 (plus adjustment for comorbidities); model 3 (plus adjustment for metabolic markers and endothelial function marker).
We conducted multinomial logistic regression analysis to determine whether increasing levels of inflammatory factors were associated with higher odds of physical functioning impairments, with adjustment for the mtDNA CN (modeled as 50th percentiles or a continuous variable), interaction terms and covariates. Model was fitted using a forward stepwise algorithm with likelihood-ratio test (stepping method criteria: probability to enter ≤ .05 and to remove ≥ .10). We applied the likelihood ratio test to examine whether the final models that included a predictor/interaction term provided a significantly better fit than did those without it. If the likelihood ratio test for the interaction term was statistically significant, we performed additional stratified analysis. p values lower than .05 were regarded as statistically significant. Ninety-five percent confidence intervals were calculated and presented for parameter estimates. All the analyses were performed using SPSS Version 19.0 (IBM Corp., Armonk, NY) or STATA Version 13.1 (StataCorp LP., College Station, TX).
Results
The mean ± SD age was 74 ± 6 years (Supplementary Table 1 ). The median mtDNA CN was 71.00 with interquartile ranges of 59.00-87.00, which is close to values observed by others (15) . A total of 634 participants (31.9 %) had severe physical functioning impairment, whereas 733 (36.8 %) had moderate physical functioning impairment and 623 (31.3 %) had normal physical functioning. Overall, participants with severe physical functioning impairment were older and had higher prevalence of comorbidities (Table 1 and  Supplementary Table 2 ).
The rotated PCA of the entire panel of the inflammatory markers generated two factors ( Table 2) . Hs-CRP, WBC count, fibrinogen, and IL-6 loaded heavily on factor 1, which was thus referred to as CRP-related. By contrast, TNFR1, D-dimer, and sIL-6r loaded heavily on factor 2, which was interpreted as TNF-α-related. These two factors collectively accounted for 50% of the variance in the participants' inflammatory markers levels.
Participants with severe physical functioning impairment had higher levels of factor 1 (CRP-related) than did those with moderate physical functioning impairment (0.15 ± 1.05 vs 0.00 ± 0.95) (p = .016) and those with normal physical functioning (0.15 ± 1.05 vs −0.14 ± 0.99) (p < .001) (Supplementary Figure 1A) . Likewise, participants with severe physical functioning impairment had higher levels of factor 2 (TNF-α-related) than did those with moderate physical functioning impairment (0.39 ± 1.00 vs −0.03 ± 0.97) (p < .001) and those with normal physical functioning (0.39 ± 1.00 vs −0.36 ± 0.90) (p < .001) (Supplementary Figure 1B) . Unlike inflammatory factors, no differences (p = .330) in the peripheral-blood leukocytes mtDNA CN among participants with different physical functioning were found (Table 1) . Results remain unchanged after adjusting for other characteristics (Supplementary Table 3) .
We observed significant correlations between the mtDNA CN and factor 1 (CRP-related) ( Figure 1A) . A strong correlation between the mtDNA CN and WBC count was noticed (r = −.286, p < .001). A multiple linear regression analysis indicated that the mtDNA CN predicted the levels of factor 1 (CRP-related), even after adjustment for sociodemographic factors, comorbidities, and metabolic and endothelial function markers (Supplementary Table 4) .
Next, we sought to determine the effects of the mtDNA CN on the relationships between inflammatory factors and physical functioning. A significant interaction between the mtDNA CN (as 50th percentiles) and factor 1 (CRP-related) on the odds of physical functioning impairment was noted. The p for interaction was .016 in the adjusted model (adjustment for age, marital status, education level, smoking status, and comorbidities). Because of this significant effect modification, additional analyses were stratified according to the mtDNA CN status. One unit increase in factor 1 (CRP-related) was associated with higher odds of moderate physical functioning impairment and higher odds of severe physical functioning impairment in participants with a low mtDNA CN but not in those with a high mtDNA CN (Table 3, model 2) .
We verified the robustness of our findings by repeating the analysis with the mtDNA CN modeled as a continuous variable. Similar results were obtained. There was a significant effect modification by the mtDNA CN (p for interaction = .008 in the fully adjusted model) (Supplementary Figure 2) . A dose-response relationship between the mtDNA CN and changes in the odds of physical functioning impairments per unit increase in factor 1 (CRP-related) was observed. For participants with −1.5 SD of the mtDNA CN (natural log-transformed and standardized), one unit increase in factor 1 (CRP-related) was associated with 0.22 (95% CI, 0.01-0.43) higher log-odds of moderate physical functioning impairment and 0.56 (95% CI, 0.34-0.78) higher log-odds of severe physical functioning impairment (Figure 2 ). By contrast, among those with 1.5 SD of the mtDNA CN , a 1-unit increase in factor 1 (CRP-related) was associated with neither a difference in the odds of moderate physical functioning impairment (changes in adjusted log-odds relative to normal physical functioning, 0.05; 95% CI, −0.16 to 0.25) nor a difference in the odds of severe physical functioning impairment (changes in adjusted log-odds relative to normal physical functioning, −0.04; 95% CI, −0.27 to 0.18) (Figure 2) . In order to examine the potential effects of outcome definitions, we also performed a sensitivity analysis using an alternative definition of low grip strength and low gait speed. The results were similar (Supplementary Figure 3) .
We observed neither correlations between the mtDNA CN and factor 2 (TNF-α-related) ( Figure 1B ) nor effect modification by the mtDNA CN on the association between factor 2 (TNF-α-related) and the odds of physical functioning impairment. One unit increase in factor 2 (TNF-α-related) was associated with higher odds of severe physical functioning impairment (Table 3 ). Repeated analysis using a different definition of low grip strength and low gait speed gave similar findings (Supplementary Table 5 ). Note: Hs-CRP = high-sensitivity C-reactive protein; IL-6 = interleukin-6; sIL-6r = soluble interleukin-6 receptor; TNFR1 = tumor necrosis factor receptor 1. a Estimated using bootstrap methods with 50 replications. Note: Hs-CRP = high-sensitivity C-reactive protein; IL-6 = interleukin-6; mtDNA CN = mitochondrial DNA copy number; sIL-6r = soluble interleukin-6 receptor; TNFR1 = tumor necrosis factor receptor 1. 
Discussion
This present study demonstrated an association between mtDNA CN and inflammation. We identified the core underlying dimensions (factors) of multiple inter-correlative inflammatory markers. The mtDNA CN was found to be strongly and inversely related to levels of the inflammatory factor related to hs-CRP, IL-6, fibrinogen, and WBC count. The greater odds of physical functioning impairment associated with higher levels of the CRP-related inflammatory factor was primarily observed in elderly people with a low mtDNA CN and increased further as the mtDNA CN declined. The results may provide new insights into the possible biological basis for the systemic inflammations and impaired physical functioning during aging.
Inflammatory Factors
Inflammation involves numerous molecules forming complex interactive networks and regulatory pathways. Through these networks and pathways specific sets of mediators are generated after noxious stimuli recognition by host receptors and subsequently elicit downstream inflammatory responses, including immune cells recruitment, and tissues/organs phenotypes alterations, in a context-specific manner (34) . Thus, patterns of inflammatory mediator/marker production and distribution could potentially reveal the details of the underlying complex inflammatory processes associated with aging and could be informative not only for the consequent phenotype alterations but also for the likely upstream initiating mechanisms.
PCA, a mathematical method that facilitates uncovering patterns underlying complex biology data (33) , was implemented in this study. We found substantial covariance among hs-CRP, IL-6, fibrinogen, and WBC count and among TNFR1, sIL-6r and D-dimer in peripheral blood, which were captured by the CRP-related inflammatory factor and the TNF-α-related inflammatory factor, respectively. These results suggest that dual systemic inflammatory processes might be at play in older adults. Although both factors were associated with impaired physical functioning, each was correlated with distinct cardio-metabolic phenotypes (data not shown). The levels of CRP-related inflammatory factor were positively correlated with triglycerides and glucose levels, whereas the TNF-α-related inflammatory factor was associated with generalized endothelial dysfunction, providing further evidence indicating that each might reflect different inflammatory processes. These findings are consistent with those of previous studies. For instance, the Health, Aging, and Body Composition Study identified similar inflammatory mediator/marker patterns, consisting of a group of mediators/markers (TNFR1, TNFR2, sIL-6r, and IL-2Sr) whose blood levels tended to change with serum TNF-α and another group (IL-6 and plasminogen activator inhibitor-1) whose blood levels changed with serum CRP (11) . Whereas levels of both groups were related (albeit differently) to physical functioning impairment, only the latter was associated with adiposity.
Mitochondrial DNA Copy Number
We did not detect an association between the leukocyte mtDNA CN and physical functioning. Previous studies examining the association have yielded conflicting results. In a study of 1067 Danish older adults, those with a lower mtDNA CN in blood cells had lower grip strength (15) . In contrast, another study of 16401 adults did not observe any significant associations between a lower mtDNA CN and low grip strength or low gait speed. An association of lower mtDNA CN in blood cells with frailty was noticed in whites but not in blacks (16) . The observed variations in the strength of the association between mtDNA CN and physical functioning remain unexplained, and may be due to the presence of unknown moderators.
Mitochondrial DNA Copy Number and Inflammatory Factors
By taking advantage of the statistical independence of the PCAderived inflammatory factors, we could identify specific markers that were uniquely associated with each inflammatory mediator/marker pattern and obtain new insights into the underlying inflammatory mechanisms. In this study, the peripheral-blood leukocyte mtDNA CN was noted to be strongly associated with levels of the CRP-related inflammatory factor but not the TNF-α-related inflammatory factor, even after controlling all other variables. As previously described, it is the CRP-related inflammatory factor that is closely related to the metabolic phenotypes. Studies have suggested that the peripheral-blood leukocyte mtDNA CN is a genetic determinant of glucose metabolism, and that a decrease of the leukocyte mtDNA CN precedes the development of metabolic disorders (25, 28) .
With the strong correlation between the mitochondrial biogenesis marker and the CRP-related inflammatory factor, we examined the influence of the leukocyte mtDNA CN on the associations between the CRP-related inflammatory factor and physical functioning. We found that this indicator of mitochondrial biogenesis was a crucial moderator of the relationship between the CRP-related inflammatory factor and physical functioning impairment. This synergistic interaction between the leukocyte mtDNA CN and inflammation as to their relationship with physical functioning also implies that a stronger association of low leukocyte mtDNA CN with physical functioning impairment could be observed in the presence of certain inflammatory processes.
Though the precise mechanisms have yet to be determined, these newly discovered correlation and synergistic interaction between the leukocyte mtDNA CN and the CRP-related inflammatory factor may reflect the complex interplays between inflammation and mitochondrial biology. During aging, proinflammatory leukocytes accumulate in ectopic fat mass, and secrete inflammatory mediators into systemic circulation, particularly IL-6, the major stimulant of hepatic CRP and fibrinogen production (21, 35, 36) . These systemic circulating inflammatory mediators, in turn, promote leukocytosis (21) . When accompanied by mitochondrial biogenesis/function decline in leukocytes resulting from either aging or inflammation, this cascade could lead to a systemic inflammation that is self-perpetuating and pathogenic in nature (18, 19, 21, 22) .
Strengths and Limitations
By applying an unsupervised statistical learning method, we uncovered patterns of covariance among multiple circulating systemic inflammatory markers and their unique relationships with the mtD-NA CN , which could be reflections of the underlying complex biological pathways in inflammations during aging. Additional strengths of this study include the blinded measurements of key variables and careful adjustments for multiple confounders in regression analysis.
Several limitations should be acknowledged. The use of a single general indicator of mitochondrial biogenesis and function might preclude complete examinations of mitochondrial roles in inflammation and physical functioning impairment in late life, for which The p for interaction between the mtDNA CN and factor 1 (CRP-related) on the odds of physical functioning impairment was .016.
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Odds ratio of a physical functioning impairment (relative to normal physical functioning) per unit increase in inflammatory factor 1 (CRP-related) or inflammatory factor 2 (TNF-α-related). Changes in log-odds of physical functioning impairments per unit increase in factor 1 (CRP-related) across the entire range of the mitochondrial DNA copy number. A dose-response relationship between mitochondrial DNA copy number and changes in odds of physical functioning impairments per unit increased in factor 1 (CRP-related) was noted. The lower the mitochondrial DNA copy number (natural log-transformed and standardized), the greater increase in the odds of severe physical functioning impairment (relative to normal physical functioning) associated with increasing levels of factor 1 (CRP-related). Prediction plot is based on the multivariable model adjusted for age, sex, marital status, education level, smoking status, and comorbidities (hypertension, diabetes mellitus, stroke, cardiovascular disease, arthritis, chronic kidney disease, cancer, and lung disease). a more comprehensive and direct measurement of mitochondrial function may be required. As determinants of mitochondrial function, mtDNA deletions often occurs during aging in consequence of the repair of mtDNA damages caused by either reactive oxygen species or replication stalling (14, 37, 38) . Cells with a low mtDNA CN might carry a high load of mtDNA deletions (26) . In light of evidence for an association between mtDNA deletions and mtDNA CN (26, 39) , further studies are warranted to examine whether and to what extent mtDNA mutations might account for the observed relationships. Second, the tissue whose average mtDNA content was measured consists of heterogenous population of immune cells. As a hallmark of immune system, this heterogeneity shapes the inflammatory responses (40) . Further insights could thus be gained from analysis of mitochondrial biogenesis and function at the level of individual cell types. The cross-sectional and observational design hindered us from making any causal inferences and obtaining definitive mechanistic insights into the observed associations and effect modifications. Nevertheless, we observed a strong correlation between the mtDNA CN and the CRP-related inflammatory factor and a dose-response effect of the leukocyte mtDNA CN on the associations between the CRP-related inflammatory factor and physical functioning. Conducting observational studies on different populations may enable confirming the consistency of the associations. Prospective studies are needed to further examine whether a change in mtDNA CN precedes a change in inflammatory markers and physical functioning, thereby reducing the likelihood of the effect-cause relationship.
Conclusions
The present study provides one of the first epidemiological evidence relating the mtDNA CN to a panel of inflammatory markers. A lower mtDNA CN of peripheral-blood leukocytes was associated with an inflammation that exhibits increased circulating hs-CRP, IL-6, fibrinogen, and white blood cell count, and strengthened the association of this inflammation with physical functioning impairment. Our epidemiological observations, coupled with emerging experimental discoveries, provide a clue to the role of mitochondria in inflammation that drives physical functioning impairment during aging. Further in-depth investigations might be worthwhile.
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